Ming Wu

Ming Wu Professor

SZU First Affiliated Hospital

Professor

Critical Care medicine

?

BIOGRAPHICAL SKETCH

?

NAME: Ming Wu

?

POSITION TITLE: Director

?

EDUCATION/TRAINING

INSTITUTION AND LOCATION

DEGREE

COMPLETION DATE

FIELD OF STUDY

Nanchang University, Nanchang, China

M.D

2008

Emergency Medicine

Southern Medical University, Guangzhou, China

Ph.D

2020

Clinical Medicine

?

?

?

?

?

A. Personal statement

I am a Professor of Critical Care medicine, a Master’s instructor and postdoctoral co-instructor, and the Director of Hospital Infection and Control.?I am primarily engaged in clinical and basic research of sepsis and acute kidney injury. I am a member of Thrombosis and Hemostasis, Chinese Research Hospital Association; ?a standing member of the Plasma Treatment Committee, Guangdong?Clinical Medical Association; a member of?Hospital Infection Management, Guangdong Province Hospital Association; and a member of?Critical Care?Medicine, Guangdong Pathophysiological Association.?I am also Vice-Chairmen of Critical Care?Medicine, Shenzhen Medical Association. At present,?I act as a reviewer of the European Journal of Internal Medicine, Kidney and Blood Pressure Research, Platelets, Renal Failure and other scientific journals.

?

B. Positions

2017-present:?Professor, First Affiliated Hospital of Shenzhen University, Shenzhen, China

2012-2017: Associate Professor, First Affiliated Hospital of Shenzhen University, Shenzhen, China

2008-2012: Attending Doctor, First Affiliated Hospital of Shenzhen University, Shenzhen, China

?

C. Representative publications (selected publications in recent five years 5-10篇)

1.Wu M, Luan YY, Lu JF, Li HL, Zhan HC, Chen TH, Zhang F, Tian YY, Yang ZL, Yao YM, Feng YW, Platelet Count as a New Biomarker for Acute Kidney Injury Induced by Haemorrhagic Shock. Platelets, 2020, 31, 1: 94-102.

2.Wu M, Li HL, Luan YY, Feng YW, Yao YM.*, Monocytopenia and Its Impact on Outcomes in Patients with Severe Sepsis Including Septic Shock: A Case-control Study. Shock, 2019, DOI: 10.1097/SHK.0000000000001493.

3.Wu M, Li NN, Xu J, Wu LF, Li ML, Tong HS, Wang F, Liu WL, Feng YW, Experimental study on the regulation of the cholinergic pathway in renal macrophages by microRNA-132 to alleviate inflammatory response, Open Chemistry, 2018,16: 176-183.

4.Wu M,Hu M, Tong HS, Liu JY, Jiang H, Zhang M, Su L, Li ML, Feng YW, Cheng B. Regulatory mechanism of ulinastatin on autophagy of macrophages and renal tubular epithelial cells, Open Chemistry, 2018, 16: 298-305.

5.Tong HS, Chen RL, Yin HM, Shi XZ, Lu JF, Zhang M, Yu BJ, Wu M, Wen Q, Su L*. Mesenteric Lymph Duct Ligation Alleviating Lung Injury in Heatstroke. Shock, 2016, 46(6): 696-703.

6.Luan YY, Jia M, Zhang H, Zhu FJ, Dong N, Feng YW, Wu M, Tong YL*, Yao YM*. The potential role and mechanism of extracellular high mobility group box-1 protein mediated p53 expression in immune dysfunction of T lymphocytes.?Oncotarget, 2017, 68(8): 112959-112971. ?

?

D. Research support

?

Ongoing projects (RMB) 1000000

?

1. Natural Science Foundation of Shenzhen Science and Technology Innovation Committee (grant no. 20190725142858543),?06/01/2020 to 5/30/2023, Ming Wu ?100000

2. Natural Science Foundation of Shenzhen Science and Technology Innovation Committee (grant no. JCYJ2017030609133500), 06/01/2017 to 5/30/2020, Ming Wu ?250000

3. Clinical Research Fund of Shenzhen Municipal Health Commission (grant no. SZLY2017007), 08/01/2017 to 7/30/2020, Ming Wu ?300000

4.?Clinical Research Project of Guangdong Province High Level Construction Hospital (grant no. 20193357003), 09/01/2017 to 8/30/2020, Ming Wu 300000

?

×

用户登录